Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

Checkpoint Inhibitor-Induced Colitis: A New Type of Inflammatory Bowel Disease?

Bertha M, Bellaguara E, Kuzel T, Hanauer S.

ACG Case Rep J. 2017 Oct 11;4:e112. doi: 10.14309/crj.2017.112. eCollection 2017.

2.

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.

Huang X, Xie X, Wang H, Xiao X, Yang L, Tian Z, Guo X, Zhang L, Tang H, Xie X.

J Exp Clin Cancer Res. 2017 Sep 15;36(1):129. doi: 10.1186/s13046-017-0593-2.

3.

EMT and Treatment Resistance in Pancreatic Cancer.

Gaianigo N, Melisi D, Carbone C.

Cancers (Basel). 2017 Sep 12;9(9). pii: E122. doi: 10.3390/cancers9090122. Review.

4.

Distinctive Surface Glycosylation Patterns Associated With Mouse and Human CD4+ Regulatory T Cells and Their Suppressive Function.

Cabral J, Hanley SA, Gerlach JQ, O'Leary N, Cunningham S, Ritter T, Ceredig R, Joshi L, Griffin MD.

Front Immunol. 2017 Aug 21;8:987. doi: 10.3389/fimmu.2017.00987. eCollection 2017.

5.

Clinical Applications of Immunotherapy Combination Methods and New Opportunities for the Future.

Esin E.

Biomed Res Int. 2017;2017:1623679. doi: 10.1155/2017/1623679. Epub 2017 Aug 7. Review.

6.

Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma.

Mansour A, Wakkach A, Blin-Wakkach C.

Front Immunol. 2017 Aug 11;8:954. doi: 10.3389/fimmu.2017.00954. eCollection 2017. Review.

7.

Dendritic Cells As Inducers of Peripheral Tolerance.

Iberg CA, Jones A, Hawiger D.

Trends Immunol. 2017 Nov;38(11):793-804. doi: 10.1016/j.it.2017.07.007. Epub 2017 Aug 18. Review.

PMID:
28826942
8.

PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis.

Que Y, Xiao W, Guan YX, Liang Y, Yan SM, Chen HY, Li QQ, Xu BS, Zhou ZW, Zhang X.

J Cancer. 2017 Jul 5;8(11):2018-2025. doi: 10.7150/jca.18683. eCollection 2017.

9.

PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.

Gu L, Chen M, Guo D, Zhu H, Zhang W, Pan J, Zhong X, Li X, Qian H, Wang X.

PLoS One. 2017 Aug 10;12(8):e0182692. doi: 10.1371/journal.pone.0182692. eCollection 2017. Review.

10.

Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.

Luo X, Peng X, Hou J, Wu S, Shen J, Wang L.

Int J Nanomedicine. 2017 Jul 26;12:5331-5343. doi: 10.2147/IJN.S137245. eCollection 2017.

11.

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer.

Kitano A, Ono M, Yoshida M, Noguchi E, Shimomura A, Shimoi T, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Kinoshita T, Fujiwara Y, Tsuda H, Tamura K.

ESMO Open. 2017 May 2;2(2):e000150. doi: 10.1136/esmoopen-2016-000150. eCollection 2017.

12.

Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.

Cho H, Kang H, Lee HH, Kim CW.

Int J Mol Sci. 2017 Jul 13;18(7). pii: E1517. doi: 10.3390/ijms18071517. Review.

13.

Concomitant Mycobacterium tuberculosis infection promotes lung tumor growth through enhancing Treg development.

Zhou Y, Hu Z, Cao S, Yan B, Qian J, Zhong H.

Oncol Rep. 2017 Aug;38(2):685-692. doi: 10.3892/or.2017.5733. Epub 2017 Jun 19.

14.

Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition.

Peer S, Baier G, Gruber T.

Oncotarget. 2017 Jun 27;8(26):41841-41853. doi: 10.18632/oncotarget.18360.

15.

Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation.

Jones A, Hawiger D.

Front Immunol. 2017 May 9;8:532. doi: 10.3389/fimmu.2017.00532. eCollection 2017. Review.

16.

PD-1 regulates KLRG1+ group 2 innate lymphoid cells.

Taylor S, Huang Y, Mallett G, Stathopoulou C, Felizardo TC, Sun MA, Martin EL, Zhu N, Woodward EL, Elias MS, Scott J, Reynolds NJ, Paul WE, Fowler DH, Amarnath S.

J Exp Med. 2017 Jun 5;214(6):1663-1678. doi: 10.1084/jem.20161653. Epub 2017 May 10.

PMID:
28490441
17.

IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.

Munn DH, Sharma MD, Johnson TS, Rodriguez P.

Cancer Immunol Immunother. 2017 Aug;66(8):1049-1058. doi: 10.1007/s00262-017-2010-2. Epub 2017 May 9. Review.

PMID:
28488123
18.

Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission.

Hughes A, Yong ASM.

Front Immunol. 2017 Apr 24;8:469. doi: 10.3389/fimmu.2017.00469. eCollection 2017. Review.

19.

Checkpoint inhibitors in hematological malignancies.

Ok CY, Young KH.

J Hematol Oncol. 2017 May 8;10(1):103. doi: 10.1186/s13045-017-0474-3. Review.

20.

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma.

Birnbaum MR, Ma MW, Fleisig S, Packer S, Amin BD, Jacobson M, McLellan BN.

JAAD Case Rep. 2017 Apr 14;3(3):208-211. doi: 10.1016/j.jdcr.2017.02.015. eCollection 2017 May. No abstract available.

Supplemental Content

Support Center